<?xml version="1.0" encoding="UTF-8"?>
<p>Here, we report the results of a prospective blinded study investigating the safety and efficacy of limited lab monitoring during HCV treatment conducted in an adult population in Rwanda, a country of 12 million inhabitants in Central Africa with an adult HCV antibody seroprevalence of approximately 3% and predominance of HCV genotype (GT) 4.
 <xref rid="hep41482-bib-0009" ref-type="ref">9</xref>, 
 <xref rid="hep41482-bib-0010" ref-type="ref">10</xref>
</p>
